Future Care Trading Co. (9544) fair value: what the stock is really worth
As of Oct 28, 2026: fair value (intrinsic value) of Future Care Trading Co. stock SAR 1.38, price SAR 1.21, upside +14.0%, quality 66 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Fair value 30%+ above price?No
Quality 50+?Yes
In an uptrend?No
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Oct 28, 2026.
How to read this chart
51‑month range 0.9427 SAR – 58.65 SAR · fair‑value band 0.8000 SAR – 1.74 SAR · the 1.21 SAR price screens below the 1.38 SAR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Oct 28, 2026.
Follow Future Care Trading Co. in your weekly email
Every Wednesday you see whether Future Care Trading Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Future Care Trading Co. operates as a home healthcare company in the Kingdom of Saudi Arabia.
Show moreShow less
The company provides medical and home healthcare services, including home medical visits, nursing care, physical therapy, heath assistant, therapeutic nutrition, psychosocial support, and personal care services.
The company also operates hospitals, specialized medical complexes, mobile medical clinics, medical clinics, plasma collection centers, and laboratories.
In addition, it engages in the operation of telemedicine centers, physiotherapy centers, and radiology centers; design and programming of special software and application development activities; medical rehabilitation centers; alternative and complementary medicine clinics; publishing of ready-made programs; audio-visual studio; and offers nursing aids and support medical services.
Future Care Trading Co. was founded in 2015 and is headquartered in Jeddah, the Kingdom of Saudi Arabia.
Stock analysis
Future Care Trading Co. (9544) currently trades at 1.21 SAR, while our model-based Fair Value estimate is 1.38 SAR, implying the stock looks roughly 12.3% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 1.11 SAR per share, and 1 of the 24 models we run sit above the 1.21 SAR price.
Bear case: the Economic Profit group reads lowest at 0.2300 SAR, and 23 of the 24 models stay below the price. Data coverage for this calculation is low.
Scenario range: 0.8000 SAR (bear) to 1.74 SAR (bull), the price of 1.21 SAR sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 66/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Future Care Trading Co. reported revenue of 76.1M SAR in FY2025 versus 72.0M SAR in FY2021, a compound +1.4%/yr. Reported net income was 15.8M SAR in FY2025, compounding −19.1%/yr from FY2021.
Key figures
Market cap 635M SAR (≈ $169M) Micro · P/E ratio 30.3 · P/S ratio 6.87 · EPS (TTM) 0.0400 SAR · Dividend yield 1.2% · Net margin 21.8% · Return on equity 20.6% · Return on assets (EBIT) 22.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 78 out of 100 (low confidence).
What moves the price
The share trades about 49% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 19% fair-value upside, at 14%, 9544 screens richer than that median.
Fair Value models
Bear0.8000 SARFair Value 1.38 SARBull1.74 SAR
Price 1.21 SAR · Upside +14.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.0215 SAR per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.80/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+41.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+30.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.4%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+24.0%
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
−57.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year−59.0%
Dividend (yield on the price)1.2%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.46% → 24%
2025 sits 52% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
⚠ Revenue per share shrinking 48.7%/yr over ~5Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+38.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Saudi Arabia: IMF forecast 2.1% a year to 2030, 1.7% from 2016 to 2025) that is about +35.7% a year for the price.
Compare Future Care Trading Co. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 244 stocks
Beats the industry median on 7/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score66 · Top 25%
Fair Value upside+14.0% · Above median
Profitability
Return on equity (12 months)20.6% · Top 25%
Return on assets14.2% · Top 25%
Net margin (12 months)21.8% · Top 25%
Operating margin (12 months)23.6% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)47.9% · Top 25%
Dividend yield (12 months)1.2% · Below median
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Future Care Trading Co. Fair Value". https://www.fairvalue-calculator.com/stock/9544
Frequently asked questions
Is Future Care Trading Co. (9544) overvalued or undervalued?
As of Oct 28, 2026, our model estimates a fair value of 1.38 SAR versus a price of 1.21 SAR, about +14% upside (undervalued).
What is the fair value of 9544?
Our model-based fair value for Future Care Trading Co. is 1.38 SAR (as of Oct 28, 2026), built from audited fundamentals. The current price: 1.21 SAR.
What is the quality score of 9544?
Future Care Trading Co. has a Quality Score of 66/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Future Care Trading Co. (9544)?
Our model-based price target is the fair value of 1.38 SAR (as of Oct 28, 2026) from 24 valuation models. Cautious scenario 0.8000 SAR, optimistic scenario 1.74 SAR. It is a calculation from audited fundamentals, not an analyst target.
What is the Future Care Trading Co. stock forecast for 2026?
Our models put fair value at 1.38 SAR, about +14% upside versus a price of 1.21 SAR (undervalued). Cautious scenario 0.8000 SAR, optimistic scenario 1.74 SAR. The calculation is refreshed regularly with new filings.
What is the revenue of Future Care Trading Co. (9544)?
Future Care Trading Co. reported trailing-twelve-month revenue of about 92.5M SAR (latest available figure, as of Oct 28, 2026).
Does Future Care Trading Co. pay a dividend?
Future Care Trading Co. currently shows a dividend yield of 1.16% relative to its recent price (as of Oct 28, 2026).
What growth is priced into Future Care Trading Co. (9544)?
For today's price to be fair in a discounted-cash-flow model, Future Care Trading Co. would have to grow free cash flow by +38.6 % per year for five years (discount rate 11.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +5.4 % per year. As of Oct 28, 2026.
What discount rate (WACC) does the fair value of 9544 use?
Our models discount Future Care Trading Co. at 11.8 %: a base by market capitalisation (micro), damped by beta 0.19, country premium for Saudi Arabia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Future Care Trading Co. that is +38.6 % per year a year over ten years, using the same discount rate (11.8 %) and the same formula as our fair value.
How much growth has Future Care Trading Co. (9544) delivered so far?
Over the past 5 years revenue at Future Care Trading Co. grew +5.4 % a year. The price currently implies +38.6 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Future Care Trading Co. (9544) growing?
The median revenue growth in the sector is +6.1 % a year. That is the yardstick for the growth priced into Future Care Trading Co. (+38.6 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Future Care Trading Co. (9544)?
The free-cash-flow yield on the price is 1.39 %: that much free cash flow Future Care Trading Co. produces per unit of market value. When it exceeds the discount rate of our models (11.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Future Care Trading Co. (9544)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Future Care Trading Co. it is 1.38 SAR per share (as of Oct 28, 2026), against a price of 1.21 SAR. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Future Care Trading Co. stock overvalued or undervalued in 2026?
As of Oct 28, 2026, 9544 trades below its calculated fair value: price 1.21 SAR, fair value 1.38 SAR, a gap of about +14% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 9544?
No. The price is what the market pays today (1.21 SAR); the fair value is what the company's own numbers justify (1.38 SAR). For Future Care Trading Co. the two are 0.1700 SAR per share apart. That gap is exactly why we show both numbers side by side.
How much is Future Care Trading Co. worth?
The market values Future Care Trading Co. at about 635M SAR (market capitalisation, as of Oct 28, 2026). Per share that is 1.21 SAR; our models calculate a fair value of 1.38 SAR per share.
What do the bullish and bearish scenarios say about 9544?
Our models span a range for Future Care Trading Co.: cautious scenario 0.8000 SAR, base 1.38 SAR, optimistic 1.74 SAR per share (as of Oct 28, 2026, price 1.21 SAR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 9544?
Future Care Trading Co. trades at a price-to-earnings ratio of 30.3 (as of Oct 28, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 1.38 SAR is built from several models across several years. Other multiples: P/B 6.6, P/S 6.9, EV/EBITDA 22.3.
How solid is the balance sheet of Future Care Trading Co. (9544)?
Balance-sheet figures for Future Care Trading Co. (as of Oct 28, 2026): return on equity 20.6%. They feed the Quality Score of 66/100, which measures business quality independently of the share price.
How far is 9544 from its 52-week high?
Future Care Trading Co. trades at 1.21 SAR, about 49% below its 52-week high of 2.38 SAR and 3% above the low of 1.17 SAR (as of Oct 28, 2026). Distance from the high says nothing about value: that is what the fair value of 1.38 SAR is for.
Which stocks are comparable to Future Care Trading Co.?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Future Care Trading Co. stock attractive at the current price?
The data as of Oct 28, 2026: price 1.21 SAR, calculated fair value 1.38 SAR (+14%), Quality Score 66/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 9544 calculated?
We run Future Care Trading Co. through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 1.38 SAR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.4 % above its aggregate fair value. Future Care Trading Co. currently trades 12 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Future Care Trading Co. (9544)?
The closing price on Oct 28, 2026 was 1.21 SAR. Our model-based fair value is 1.38 SAR, about +14% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Future Care Trading Co. right now?
A fairly wide model range (0.8000 SAR to 1.74 SAR) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Future Care Trading Co.
How large is the market capitalisation of Future Care Trading Co. (9544)?
The market capitalisation of Future Care Trading Co. is 635M SAR (≈ $169M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Future Care Trading Co. (9544)?
The price-to-sales ratio of Future Care Trading Co. is 6.87 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Future Care Trading Co. (9544)?
Earnings per share at Future Care Trading Co. are 0.0400 SAR (price ÷ EPS = P/E 30.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Future Care Trading Co. (9544)?
The dividend yield of Future Care Trading Co. is 1.2% (payout 35.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Future Care Trading Co. (9544)?
The net margin of Future Care Trading Co. is 21.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Future Care Trading Co. (9544)?
The return on equity (ROE) of Future Care Trading Co. is 20.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Future Care Trading Co. (9544)?
On an EBIT basis the return on assets of Future Care Trading Co. is 22.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Future Care Trading Co. (9544)?
The operating margin of Future Care Trading Co. is 23.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Future Care Trading Co. (9544)?
Revenue at Future Care Trading Co. is growing +47.9% versus a year earlier (3y avg +30.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Future Care Trading Co. (9544)?
Earnings per share at Future Care Trading Co. are growing +53.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Future Care Trading Co. (9544) hold?
Future Care Trading Co. holds more cash than debt, 56.0M SAR net (fiscal year 2024). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Future Care Trading Co. in the live analysis
One click puts Future Care Trading Co. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Thin data
Oct 28, 2026